Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli

Complete biosynthesis of opioids in yeast

A microbial biomanufacturing platform for natural and semisynthetic opioids

Metabolic engineering with a morphine biosynthetic P450 in opium poppy surpasses breeding

Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae

Redesign of a dioxygenase in morphine biosynthesis

Metabolic engineering of yeast for production of kratom monoterpene indole alkaloids

A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

The Development of a Practical Total Synthesis of Natural and Unnatural Codeine, Morphine and Thebaine

A yeast platform for high-level synthesis of natural and unnatural tetrahydroisoquinoline alkaloids

Microbial production of plant benzylisoquinoline alkaloids

Microbial Factories for the Production of Benzylisoquinoline Alkaloids

Endophytic Consortium With Diverse Gene-Regulating Capabilities of Benzylisoquinoline Alkaloids Biosynthetic Pathway Can Enhance Endogenous Morphine Biosynthesis in Papaver somniferum

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Metabolic engineering of yeast for de novo production of kratom monoterpene indole alkaloids

Biosynthesis of cannabinoid precursor olivetolic acid in genetically engineered Yarrowia lipolytica

Systematic knockdown of morphine pathway enzymes in opium poppy using virus-induced gene silencing

Advances of the total synthesis of morphine in the last decade

Complete biosynthesis of cannabinoids and their unnatural analogues in yeast

Engineering Escherichia coli native metabolism for efficient biosynthesis of orotate